Zoetis Inc. (ZTS)
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Address
10 SYLVAN WAY
PARSIPPANY, NJ 07054
Founded
1952
Number of Employees
14,100
Website
http://www.zoetis.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
$36 | $202,455 | $312,962 | $510,722 | $716,522 | $659,174 | $287,636 | $814,569 | $1,645,015 | $1,106,187 | $895,997 | $650,116 |
Average Price | $37.77 | $45.89 | $47.27 | $60.25 | $84.73 | $107.38 | $134.18 | $183.33 | $169.05 | $172.22 | $174.38 | $115.37 |
# Shares Purchased | 951 | 4,411,362 | 6,620,575 | 8,477,017 | 8,456,120 | 6,138,753 | 2,143,651 | 4,443,109 | 9,731,003 | 6,423,271 | 5,138,109 | 5,634,902 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | 405.7% | 316.2% | 304.1% | 217.0% | 125.4% | 77.9% | 42.3% | 4.2% | 13.0% | 10.9% | 9.5% | 65.5% |
S&P 500 Return to Date | 181.9% | 173.0% | 168.6% | 129.7% | 104.9% | 93.1% | 74.8% | 31.7% | 37.3% | 31.3% | 7.4% | 94.0% |
Excess Total Return | 223.8% | 143.2% | 135.5% | 87.3% | 20.5% | -15.2% | -32.5% | -27.5% | -24.3% | -20.4% | 2.1% | -28.4% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | 88% | 86% | 86% | 84% | 79% | 70% | 52% | 49% | 58% | 50% | 59% | 76% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)